{"name":"Strides Pharma Science","slug":"strides","ticker":"STAR.NS","exchange":"NSE","domain":"stfridesglobal.com","description":"Strides Pharma Science Limited is an Indian pharmaceutical company, headquartered at Bangalore. The company manufactures pharmaceutical products, over-the-counter drugs and nutraceuticals. Products include softgel capsules, hard-gel capsules, tablets and dry and wet injectables. The company has 15 manufacturing sites in six countries and marketing presence in 50 countries. The company partners with generic companies to supply retail and hospital generics in injectable products and softgels. The company's stock trades on the Bombay Stock Exchange and on the National Stock Exchange of India.","hq":"Bengaluru, Karnataka, India","founded":0,"employees":"3301","ceo":"Arun Kumar (Founder & Executive Chairman)","sector":"Regulated Market Generics — Soft Gelatin Capsules / Controlled Substances","stockPrice":1155.4,"stockChange":9,"stockChangePercent":0.79,"marketCap":"$1.1B","metrics":{"revenue":493520433.7096704,"revenueGrowth":3.6,"grossMargin":56.2,"rdSpend":0,"netIncome":53412740.994835205,"cash":23754765.460835204,"dividendYield":0.35,"peRatio":20.8,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Losartan patent cliff ($1.4B at risk)","drug":"Losartan","type":"patent_expiry","sentiment":"negative"},{"date":"2026-06-01","label":"Metformin patent cliff ($1.2B at risk)","drug":"Metformin","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-14","type":"earnings","headline":"Strides Pharma Science reports Q3 FY2024 results","summary":"The company reported a revenue of ₹1,444.8 crore and a net profit of ₹143.8 crore for the quarter.","drugName":"","sentiment":"neutral"},{"date":"2023-08-22","type":"deal","headline":"Strides Pharma Science partners with US-based company for generic drug development","summary":"The partnership aims to develop and commercialize generic versions of several key drugs in the US market.","drugName":"","sentiment":"positive"},{"date":"2023-05-15","type":"regulatory","headline":"Strides Pharma Science receives FDA approval for generic version of Losartan","summary":"The company has received approval from the US FDA for its generic version of Losartan, a key hypertension medication.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNVTlfMGZxU0NVZzlGNkNvSnYxQjBRLXJIV3BRYWphdGhBSTZfRS1NUlBGVmhhTkRZU0RyVElRRlpzZDktLUVhU0NvWG5mdHc2aWk5X250UVR3VTZnaEFicmJYSEoyQlRSRHhOOTdYXzB3RmswSTRQb0xUVFBpbzI3UEpkcWozNU1ZNDk0ZGpBUDNIUQ?oc=5","date":"2025-09-09","type":"deal","source":"Yahoo Finance","summary":"Kenox Enters into Strategic Product Development Partnership with Strides - Yahoo Finance","headline":"Kenox Enters into Strategic Product Development Partnership with Strides","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFB3czJ5Q1dIeUdNb0c4RFdiNUZMZm9rZlFCa3BpVWhESUdTcnF5MGR0Mm4yamE1NllmaVM0Um5WbUpMSXdpc0M4ZHllUjVNTnBzRU9DcWlXNGgwdw?oc=5","date":"2025-05-27","type":"pipeline","source":"Yahoo Finance Singapore","summary":"COHANCE LIFESCIENCES LTD (COHANCE.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"COHANCE LIFESCIENCES LTD (COHANCE.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFBITjBKaHZoLXJUUkhwemZmN19PS1ZWM3l1V0VjMzR3MGZVZlVxODhYbXlqaXptLUdJY2pxYW1Lemd1cW9abUZlRHBiS2NWMU1Gc1l3ZmhDbGp1OWRSQWdUcTN3cHBiWWRQYzBnUUw1eE9XdThxSVBUakRyaml4UQ?oc=5","date":"2024-10-01","type":"pipeline","source":"Yahoo Finance","summary":"Bandhan Bank And 2 Other Stocks That May Be Undervalued On The Indian Exchange - Yahoo Finance","headline":"Bandhan Bank And 2 Other Stocks That May Be Undervalued On The Indian Exchange","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTFB4QW5EdHRvOGtlWjN2Qzh3dXBQb3kwQnV6YjR6S0pnOWFIRDA1YXVDNnFVZGNUM3RodEFXUmZKbWZkU2ZzbGFGQ1pHY2RfRnZNQlh1YUprREpseW1yd1V3MWE4SzJ3WjFl?oc=5","date":"2024-09-18","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Laurus Labs Limited (LAURUSLABS.NS) company profile and facts - Yahoo Finance Singapore","headline":"Laurus Labs Limited (LAURUSLABS.NS) company profile and facts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE82X0JMTVZkOUhDVWJYa0dvYnlGVnc1bkxQbERJbkRlUzF2YWx1SlBzMDVsQjFZREdGZVBYbzI4SlJtN1JfdURyaEpWdlB6bjZsNVFVRGJUMnNpUjlZelE?oc=5","date":"2022-05-02","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Laurus Labs Limited (LAURUSLABS.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Laurus Labs Limited (LAURUSLABS.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTE4yZ1oyZHVfV0t4YXo1N1h6SE4ySy01WHUtQzdhbWRVdWFnNkFxUExQdkIybzg1ck5NLUlZMEt0eUV4NmFpWndnSlBWZVpyVlpkR3lWM1BoMA?oc=5","date":"2017-06-06","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Suven Life Sciences Limited (SUVEN.NS) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Suven Life Sciences Limited (SUVEN.NS) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiV0FVX3lxTFBsMDBDNnV5aUc1Q08ySXg3WGM0emQtdnVnN283bnE2VmZBU2JRajhVejVyaVh0Z0NoZU9Ba1Q4YkVjZERpR3hlTTg4aVA4aTV5T2hLRmxaQQ?oc=5","date":"2017-05-24","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Sun Pharma Advanced Research Company Limited (SPARC.NS) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Sun Pharma Advanced Research Company Limited (SPARC.NS) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTE9YQ3MyTHQ1bHFyYTVMODJaaUFHTm4tOUFUdFVOMjI5SDZtRThhemIxX3hqZVd4TF92Q1lnX2xMZmhrVjdNNnBJb1ktQTh0OXVDRzYxazFn?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance UK","summary":"Strides Pharma Science Limited (STAR.NS) stock price, news, quote and history - Yahoo Finance UK","headline":"Strides Pharma Science Limited (STAR.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE9kbWN1aGxhS0h6SkNxZFlJLUl1VldUOWZQU042X0FKRUJNU2NKN0x1V012a3d1RDRMMUxUQmlWMHNBX0lPZEhNQ25EUmNzUkkzTVYwaDRqMmkwaHBxa1E?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Wockhardt Limited (WOCKPHARMA.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Wockhardt Limited (WOCKPHARMA.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE81M09rdXk0VGNvb09nU053X0Y2ZS1hcGdSOU80dk9vZzVqLUFNc2ZfX3ZwZzUxMGV4aU83ZXVINmhudkNOZXJxbHhtbjdPMTg2aVkwYzExWE9XOEo1?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Shilpa Medicare Limited (SHILPAMED.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Shilpa Medicare Limited (SHILPAMED.NS) stock price, news, quote and history","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE04WnpqNWd4eU41TWRjZmpBWnoxWF9ycjJfcTBZNzBnTnpRUEFHeDU0SmVoZEh4SER6c1JsUVp1VF82cEVld1VzOGZxNDgyZnhZelUySXpnQ3pnRTFGYXc?oc=5","date":"2017-05-20","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Morepen Laboratories Limited (MOREPENLAB.NS) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Morepen Laboratories Limited (MOREPENLAB.NS) stock price, news, quote and history","sentiment":"neutral"}],"patents":[{"drugName":"Losartan","drugSlug":"losartan","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":1400000000},{"drugName":"Metformin","drugSlug":"metformin","patentNumber":"","type":"Patent Cliff","expiryDate":"2026-06-01","territory":"US","annualRevenue":1200000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Aurobindo Pharma","Cipla","Sun Pharmaceutical"],"therapeuticFocus":["Cardiovascular","Diabetes"],"financials":{"source":"yahoo_finance","revenue":458646956.55075,"revenuePeriod":"2025-03-31","revenueHistory":[{"period":"2025-03-31","value":458646956.55075},{"period":"2024-03-31","value":389546350.763625},{"period":"2023-03-31","value":376768264.89087504},{"period":"2022-03-31","value":315609551.63100004}],"grossProfit":235791161.04912502,"grossProfitHistory":[{"period":"2025-03-31","value":235791161.04912502},{"period":"2024-03-31","value":192836891.311625},{"period":"2023-03-31","value":194439765.44712502},{"period":"2022-03-31","value":145217806.67900002}],"rdSpend":null,"rdSpendHistory":[],"sgaSpend":44261174.02025,"operatingIncome":60531056.656125,"operatingIncomeHistory":[{"period":"2025-03-31","value":60531056.656125},{"period":"2024-03-31","value":33532423.511125002},{"period":"2023-03-31","value":14921830.815375},{"period":"2022-03-31","value":-25247356.341625}],"netIncome":375283820.47062504,"netIncomeHistory":[{"period":"2025-03-31","value":375283820.47062504},{"period":"2024-03-31","value":-7374390.6995},{"period":"2023-03-31","value":-21162262.213125},{"period":"2022-03-31","value":-48062308.364125006}],"eps":390.5,"epsHistory":[{"period":"2025-03-31","value":390.5},{"period":"2024-03-31","value":-7.76},{"period":"2023-03-31","value":-22.49},{"period":"2022-03-31","value":-51.28}],"cash":11755663.5515,"cashHistory":[{"period":"2025-03-31","value":11755663.5515},{"period":"2024-03-31","value":16816184.0825},{"period":"2023-03-31","value":31696240.747875},{"period":"2022-03-31","value":17830251.57375}],"totalAssets":631700863.646875,"totalLiabilities":361582525.882875,"totalDebt":196300177.217375,"equity":266501427.42162502,"operatingCashflow":71472855.33025001,"operatingCashflowHistory":[{"period":"2025-03-31","value":71472855.33025001},{"period":"2024-03-31","value":73215986.17437501},{"period":"2023-03-31","value":4638079.4391250005},{"period":"2022-03-31","value":-26925006.205625}],"capex":-25325369.56675,"capexHistory":[{"period":"2025-03-31","value":-25325369.56675},{"period":"2024-03-31","value":-12339143.991625002},{"period":"2023-03-31","value":-9914885.63175},{"period":"2022-03-31","value":-14974257.373625001}],"freeCashflow":46147485.763500005,"dividendsPaid":-2400969.27125,"buybacks":null,"employees":3301,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":null,"ebit":30166575.810250003,"ebitda":35453407.798875004,"period":"2025-12-31","revenue":124763303.00225002,"epsBasic":21.93,"netIncome":21107120.335125003,"rdExpense":null,"epsDiluted":21.92,"grossProfit":76415886.064375,"operatingIncome":19354172.565750003},{"sga":null,"ebit":17702109.368625,"ebitda":22807537.110875003,"period":"2025-06-30","revenue":116940049.061,"epsBasic":10.81,"netIncome":10402598.833,"rdExpense":null,"epsDiluted":10.81,"grossProfit":70541187.349875,"operatingIncome":17669212.225500003},{"sga":null,"ebit":12039205.594625002,"ebitda":17141918.017125003,"period":"2025-03-31","revenue":106183623.17750001,"epsBasic":null,"netIncome":8583961.21275,"rdExpense":null,"epsDiluted":null,"grossProfit":37996618.050875,"operatingIncome":14418243.437125001},{"sga":null,"ebit":17339092.005125,"ebitda":22396270.604125,"period":"2024-12-31","revenue":120483645.770125,"epsBasic":9.56,"netIncome":9184673.48975,"rdExpense":null,"epsDiluted":9.55,"grossProfit":70341715.783625,"operatingIncome":16906833.988},{"sga":null,"ebit":16713001.932000002,"ebitda":21773209.156875003,"period":"2024-09-30","revenue":121869189.89025001,"epsBasic":7.81,"netIncome":7502950.646125001,"rdExpense":null,"epsDiluted":7.8,"grossProfit":64323105.122375004,"operatingIncome":14218980.741625002}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":1155.4,"previousClose":1146.4,"fiftyTwoWeekHigh":1231,"fiftyTwoWeekLow":654.4,"fiftyTwoWeekRange":"654.4 - 1231.0","fiftyDayAverage":986.79,"twoHundredDayAverage":904.93,"beta":0.31,"enterpriseValue":1285753679.0337536,"forwardPE":15.9,"priceToBook":3.86,"priceToSales":2.25,"enterpriseToRevenue":2.6,"enterpriseToEbitda":14.46,"pegRatio":0,"ebitda":88903278.15952,"ebitdaMargin":18,"freeCashflow":0,"operatingCashflow":0,"totalDebt":192563469.30698243,"debtToEquity":65.8,"currentRatio":0,"returnOnAssets":0,"returnOnEquity":0,"analystRating":"","recommendationKey":"none","numberOfAnalysts":2,"targetMeanPrice":1264,"targetHighPrice":1409,"targetLowPrice":1119,"dividendRate":4,"payoutRatio":0.07,"fiveYearAvgDividendYield":1.23,"exDividendDate":1753142400,"insiderHeldPercent":30.8,"institutionHeldPercent":27,"sharesOutstanding":92172714,"floatShares":56689492,"sharesShort":0,"shortRatio":0,"shortPercentOfFloat":0,"epsTrailing":55.49,"epsForward":72.55,"revenuePerShare":512.72,"bookValue":299.06,"officers":[{"age":64,"name":"Mr. Arun Kumar Pillai B.Com.","title":"Founder & Non-Executive Chairperson"},{"age":53,"name":"Mr. Badree  Komandur","title":"MD & Group CEO"},{"age":40,"name":"Mr. Vikesh  Kumar","title":"Group CFO"},{"age":null,"name":"Ms. Manjula  Ramamurthy","title":"Compliance Officer & Company Secretary"},{"age":null,"name":"Mr. Aditya Arun Kumar","title":"Executive Director of Business Development & Director"},{"age":null,"name":"Mr. P. V. S. Ramaraju","title":"Chief Operating Officer"},{"age":null,"name":"Ms. Sormistha  Ghosh","title":"Group General Counsel, Chief Risk Officer & Chief Sustainability Officer"},{"age":null,"name":"Ms. Nandini  Matiyani","title":"Executive Vice President of Human Resources"}],"industry":"Drug Manufacturers - Specialty & Generic","irWebsite":"","website":"https://www.strides.com","phone":"91 80 6784 0000"}}